A phase III study of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Gemcabene (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- 15 Mar 2018 According to a Gemphire Therapeutics media release, company plans to initiate this trial in second half of 2018, once agreement with the FDA is reached.
- 19 Sep 2017 According to a Gemphire Therapeutics media release, company plans to initiate this trial in 2018.
- 03 Feb 2017 New trial record